Curis
CRIS
#10228
Rank
NZ$26.2 M
Marketcap
NZ$2.03
Share price
-0.85%
Change (1 day)
-66.17%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$74.1 Million, an increase over its 2023 earnings that were of -NZ$78.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-24.13%
2024 -NZ$74.1 Million-5.77%
2023 -NZ$78.64 Million-13.1%
2022 -NZ$90.49 Million27.52%
2021 -NZ$70.96 Million65.09%
2020 -NZ$42.99 Million-9.1%
2019 -NZ$47.29 Million-4.73%
2018 -NZ$49.63 Million-41.95%
2017 -NZ$85.49 Million-14.37%
2016 -NZ$99.84 Million3.55%
2015 -NZ$96.41 Million271.52%
2014 -NZ$25.95 Million76.64%
2013 -NZ$14.7 Million
2011 -NZ$12.48 Million27.76%
2010 -NZ$9.77 Million-43.87%
2009 -NZ$17.4 Million-23.44%
2008 -NZ$22.73 Million56.66%
2007 -NZ$14.51 Million-16.71%
2006 -NZ$17.42 Million-36.92%
2005 -NZ$27.62 Million156.25%
2004 -NZ$10.78 Million-37.24%
2003 -NZ$17.17 Million-93.34%
2002 -NZ$0.26 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
NZ$1.51 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.53 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.91 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.83 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA